RE: Ship Boarding27 Oct 2020 12:51
Graham201986,
This is from Parexel who are running the trial and they state that it is a double blind trial, this seems different from opinions on here so can this be the wrong from Parexel as if it is indeed a double blind trial then would this not make a large difference to being able to stop for benefit or have live data available? thoughts on this anyone?
Synairgen’s study will evaluate the ability of SNG001, an inhaled formulation of IFN-beta-1a, to
accelerate recovery among hospitalized patients receiving oxygen. The randomized, doubleblind,
placebo-controlled trial is expected to enroll 900 patients across approximately 20
countries.